Saccharomyces boulardii
RxNorm 236782
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 236782 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Saccharomyces boulardii.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing Saccharomyces boulardii (medicinal product)
(Atom ID: 10303860)
INPrescribable
Ingredient (IN):
Saccharomyces boulardii
(Atom ID: 1218971)
PTPrescribable
Designated preferred name (PT):
Saccharomyces boulardii
(Atom ID: 6389876)
FNPrescribable
Full form of descriptor (FN):
Saccharomyces boulardii (substance)
(Atom ID: 6389877)
PTPrescribable
Designated preferred name (PT):
Saccharomyces boulardii-containing product
(Atom ID: 10820474)
Patient Education
Saccharomyces Boulardii
What is it? Saccharomyces boulardii is a yeast believed to be a strain of Saccharomyces cerevisiae. It is likely effective for treating certain types of diarrhea.
Saccharomyces boulardii is called a "probiotic," a friendly organism that helps to fight off "bad" organisms that might cause diseases. Saccharomyces boulardii is different from other strains of Saccharomyces cerevisiae, commonly known as brewer's yeast and baker's yeast.
Saccharomyces boulardii is most commonly used for treating and preventing diarrhea, including rotaviral diarrhea in children. It has some evidence of use for other types of diarrhea, acne, and a digestive tract infection that can lead to ulcers. There is no good evidence to support using Saccharomyces boulardii for COVID-19.
[Learn More]
* Please review the disclaimer below.